Close

Pfizer (PFE) in Global Blood Therapeutics (GBT) Takeover Talks

August 5, 2022 11:54 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Pfizer (NYSE: PFE) is reportedly in advanced talks to acquire Global Blood Therapeutics (NYSE: GBT), according to a report by The Wall Street Journal Friday.

The news follows Thursday's report by Bloomberg that large pharmaceutical companies are eyeing a potential takeover deal for Global Blood Therapeutics.

Pfizer is said to be discussing a potential $5 billion takeover of Global Blood Therapeutics. The company's drug for sickle-cell disease was recently approved. The move would bolster Pfizer's portfolio and pipeline.

The WSJ said its sources told them Pfizer is aiming to seal a deal for GBT within the coming days. However, there is no guarantee of a deal, and other companies are said to be "still in the mix."

GBT shares popped 41% following Thursday's report and have gained another 9.5% Friday.

By Sam Boughedda



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

General News, Hot List, Mergers and Acquisitions, Rumors

Related Entities

Definitive Agreement